A new research has highlighted the potential significance of the proposed tariffs by the United States on the global economy.
Biohaven's NDA for Troriluzole was accepted by the FDA, potentially leading to approval in Q3 2025. Click here to find out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback